Genespire is currently owned by Sofinnova Partners, through Sofinnova Capital IX, since 2020.

When did Sofinnova Partners acquire Genespire?

Sofinnova Partners acquired Genespire in 2020 (active for 6 years).

Home/Companies/Biotech/Genespire

Genespire

Biotech·

Italy·Active·6yr hold

Genespire is a healthcare / biotech company, headquartered in Italy.

Entry

2020

Hold

6yr

Status

Active

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQItaly

SectorHealthcare / Biotech

Italian biotech developing transformative gene therapies for primary immunodeficiencies and inherited metabolic disorders.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Sofinnova Capital IX

Other portfolio companies in the same fund.

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings